Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 126   

Articles published

SHP 3,624.18 -147.98 (-3.92%)
price chart
Shire plc Director and Senior Management Changes
August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company"), announces changes to its Executive Committee, as it progresses its strategy to sharpen its focus as a leader in rare diseases.
Shire CFO Poulton to depart for Boston startup  Financial Times
TOP NEWS: Shire Chief Financial Officer To Leave At End Of 2017  Interactive Investor
Shire plc (SHPG): Can the high growth still justify its August share price?
Shire plc (NASDAQ:SHPG) closed yesterday at $145.55, leaving some investors asking whether this price can still be justified by the high growth potential.
Cantor Fitzgerald Reaffirms “Buy” Rating for Shire PLC (SHPG)  TrueBlueTribune
Investors Must-Watch: Shire plc (SHPG)  StandardOracle
Shire seeks European marketing approval for dry eye drops
FTSE 100 speciality pharma giant Shire PLC (LON:SHP, NASDAQ:SHPG) said it is making progress in securing marketing approval in Europe for Lifitegrast for dry eye disease.
EXTRA: Shire Submits Marketing Application For Lifitegrast In Europe  Interactive Investor
Shire Gains as it Seeks European Approval For Dry Eye Treatment  TheStreet.com
BHP Billiton plc and Shire plc could be the FTSE 100's best bargains
Around six years ago, FTSE 100 mining stocks were booming -- and BHP Billiton(LSE: BLT) shares reached 2,475p in April 2011. But Chinese demand was slowing, a worldwide oversupply pushed metals and minerals prices down, and we've had a sector ...
Shire Plc (SHPG) Q2 2017 Results - Earnings Call Transcript
For those not able to be the webcast, slides that accompany today's call are located on the Presentations and Webcasts page of shire.com. Our speakers today are Chief Executive Officer, Dr. Flemming Ornskov, and, Jeff Poulton, Shire's Chief Financial ...
Shire in demand after second-quarter results amid neuroscience spin-off hopes
Shire Pharma PLC (LON:SHP) was a good FTSE 100 gainer in mid afternoon trading, adding 3.5% at 4,345.5p after the drugs maker said it is mulling a separate listing for its neuroscience franchise as it revealed the cost savings from the US$32bn takeover ...
Shire Q2/2017: Market Reaction Makes No Sense  Seeking Alpha
Shire's ADHD Spinoff Idea Is Shaky  Bloomberg
Shire PLC (SHP): Looking To Captalise On Unmet Needs In Eye Care
Irish biotech giant Shire plc (LON:SHP) received a validation from the UK, in the capacity of the Reference Member State, for its marketing authorization application for lifitegrast.
Market Risers: Shire PLC, Standard Chartered PLC, Tesco PLC
The stock price for Shire PLC with EPIC code: LON:SHP has moved up 1.61% or 61 points during today's session so far. Market buyers seem confident throughout the trading session.
Shire PLC (LON:SHP) Rating Reiterated by Credit Suisse Group AG  BNB Daily (blog)
Analyst at Shore Capital Reaffirmed The Shire PLC (LON:SHP) Buy Rating They ...  WeeklyHub
Shire plc : Total voting rights
As at July 31, 2017, the Company's issued ordinary share capital comprised 908,114,281 ordinary shares of 5 pence each with voting rights and a further 7,357,283 ordinary shares held in treasury.
Don't Lose The Faith In Shire
In spite of share price underperforming its peers since 1st January 2017, I think the strengths and opportunities of Shire have still been overlooked by the market.